These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11892489)

  • 21. Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardiographic study.
    Agmon Y; Khandheria BK; Meissner I; Petterson TM; O'Fallon WM; Christianson TJ; Wiebers DO; Smith TF; Steckelberg JM; Tajik AJ
    J Am Coll Cardiol; 2003 May; 41(9):1482-7. PubMed ID: 12742286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chlamydia pneumoniae-induced atherosclerosis in a rabbit model.
    Muhlestein JB
    J Infect Dis; 2000 Jun; 181 Suppl 3():S505-7. PubMed ID: 10839748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydia pneumoniae and vascular disease: an update.
    Mussa FF; Chai H; Wang X; Yao Q; Lumsden AB; Chen C
    J Vasc Surg; 2006 Jun; 43(6):1301-7. PubMed ID: 16765261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis.
    Leinonen M; Saikku P
    Am Heart J; 1999 Nov; 138(5 Pt 2):S504-6. PubMed ID: 10539859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chlamydia and arteriosclerosis: a few grey areas still remain].
    Lapetra-Peralta J; Santos-Lozano JM
    Rev Neurol; 2001 Feb 1-15; 32(3):232-3. PubMed ID: 11310275
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Ioannidis A; Boufidou F; Moutafis S; Nicolaou C
    Nephrology (Carlton); 2005 Jun; 10(3):256-63. PubMed ID: 15958038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Implication and mode of action of infectious agents in the formation of atheromatous plaques. Infection and atherosclerosis].
    Lizard G; Gambert P
    Pathol Biol (Paris); 2001 Dec; 49(10):824-9. PubMed ID: 11776694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chlamydia pneumoniae and cerebrovascular disease].
    Linares-Palomino J; Gutiérrez J; López-Espada C; Ros E; Moreno J; Pérez T; Rodríguez M; Maroto MC
    Rev Neurol; 2001 Feb 1-15; 32(3):201-6. PubMed ID: 11310268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications].
    Nagornev VA; Mal'tseva SV; Seliverstova VG; Sokurenko GIu; Voskan'iants AN
    Arkh Patol; 2004; 66(2):52-60. PubMed ID: 15154386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Persistence of Chlamydia pneumoniae in human arteriosclerotic plaque substance. Evidence and consequences].
    Maass M
    Herz; 1998 May; 23(3):178-84. PubMed ID: 9646099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
    Jaber AJ; Murín J; Hricák V; Tomasovic B; Kinová S; Kozlíková K; Ghanem W; Radman A
    Vnitr Lek; 2003 Feb; 49(2):109-14. PubMed ID: 12728577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between Chlamydia pneumoniae and atherosclerosis].
    Gayet A; Baril L; Orfila J
    Presse Med; 2001 Dec; 30(36):1792-801. PubMed ID: 11771205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collaborative multidisciplinary workshop report: what questions regarding the role of Chlamydia pneumoniae in atherosclerosis and cardiovascular disease need to be addressed utilizing animal models?
    Fong IW; Quinn T; Blessing E; Kuo C; Malinverni R; Lauer M; Mawhorter S; Bachmaier K; Rosenfeld M; Taylor C; Zhong G
    J Infect Dis; 2000 Jun; 181 Suppl 3():S519-20. PubMed ID: 10839751
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlamydia pneumoniae and atherosclerosis.
    Hoymans VY; Bosmans JM; Ieven M; Vrints CJ
    Acta Chir Belg; 2002 Oct; 102(5):317-22. PubMed ID: 12471763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The past, present and future of arterial infection].
    Capron L; Loire R
    Rev Prat; 1994 Apr; 44(7):906-10. PubMed ID: 7939301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of atherosclerosis: a possible relation to infection.
    Noll G
    Atherosclerosis; 1998 Oct; 140 Suppl 1():S3-9. PubMed ID: 9859918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.
    Vainas T; Sayed S; Bruggeman CA; Stassen FR
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():165-72. PubMed ID: 20011710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlamydia pneumoniae and atherosclerosis.
    Ieven M
    Verh K Acad Geneeskd Belg; 2001; 63(5):433-45; discussion 446. PubMed ID: 11813502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.